The Catalan biopharmaceutical company AbilityPharma, focused on the development of innovative oral anticancer compounds, undertakes a collective investment campaign of up to 2 million on the Capital C...
Read moreAuthors from CSIC and CNIO propose that cognitive loss in patients with brain metastases may be due to the interference created by the cancer in neuronal circuits
Read moreGradient Denervation Technologies (“Gradient”), a medical device company developing an innovative catheter-based solution for the treatment of pulmonary hypertension, announces today the successfu...
Read moreInvestigadores del Cima Universidad de Navarra confirman que las proteínas cIAPs desempeñan un papel crucial en la activación y función de los linfocitos a través del receptor CD137 y promueven s...
Read moreEl Instituto de Investigación Sanitaria INCLIVA, del Hospital Clínico de València, ha estado impulsando en los últimos años la investigación en sepsis para avanzar en los métodos de prevención...
Read moreLa administración de rituximab en combinación con quimioterapia ha mejorado de forma significativa la tasa de supervivencia en pacientes pediátricos niños y adolescentes con linfoma no Hodgkin de ...
Read moreThe eleven accelerated companies in the BCN Health Booster raised €16.4 M of private capital, and €35.4 M of public funding during 2022, the first year of the programme’s launch, a period in whi...
Read moreEl Corte Inglés steps up its cooperation with the Spanish Association Against Cancer (AECC) by allocating one million euros over the next five years to fund a new research project.
Read moreSe trata del primer ensayo clínico en el mundo para evaluar el uso de estos métodos no invasivos antes de una intervención de tumor cerebral. Su aplicación permitiría reducir el número de cirug...
Read moreRecently published in the journal Cell Reports, results of a VHIO-led study identify the overexpression of DPPA3 factor as a key regulator of “slow-cycliness” in colorectal cancer which could act ...
Read moreThis project aims to understand fundamental aspects of oocyte development which might help address unexplained infertility, which accounts for around one in four cases of infertility
Read moreLa empresa, dirigida por el doctor Pablo Escribá, ha desarrollado Lam561, un fármaco específico para combatir el glioblastoma y prolongar la esperanza de vida de los pacientes afectados por este ti...
Read more